N. Rawson

发表

Inferential Problems in Postmarketing Surveillance

D. Lane, N. Rawson, 1989 .

Access to linked administrative healthcare utilization data for pharmacoepidemiology and pharmacoeconomics research in Canada: anti‐viral drugs as an example

N. Rawson, 2009, Pharmacoepidemiology and drug safety.

Examples of Automated Databases

S. Kimmel, K. Chan, H. Leufkens, 2013 .

Reliability of the recording of hysterectomy in the Saskatchewan health care system

N. Rawson, Lindsay Edouard, 1996, British journal of obstetrics and gynaecology.

Concordance on the Recording of Cancer in the Saskatchewan Cancer Agency Registry, Hospital Charts and Death Registrations

D. Robson, N. Rawson, 2000, Canadian journal of public health = Revue canadienne de sante publique.

Issues in the approval of, access to, and post‐marketing follow‐up of new drugs in Canada: a personal viewpoint

N. Rawson, 2002, Pharmacoepidemiology and drug safety.

Epidemiology in the pharmaceutical Industry: a Canadian perspective

L. D. De Souza, N. Rawson, 2006, Pharmacoepidemiology and drug safety.

Letter to ISPE commentary editor

N. Rawson, 2003, Pharmacoepidemiology and Drug Safety.

Documented tuberculin skin testing among infliximab users following a multi‐modal risk communication interventions

J. Allison, L. Moreland, M. Braun, 2006, Pharmacoepidemiology and drug safety.